logo
episode-header-image
Aug 2024
21m 14s

Renal Cell Carcinoma

JAMA NETWORK
About this episode

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.

Related Content:

Up next
Yesterday
Resistant Hypertension: Diagnosis and Management
Resistant hypertension affects about 10% of those treated for hypertension. Managing it involves lowering sodium intake, exercising, losing weight, reducing alcohol consumption, and using optimal diuretics, combination pills, and mineralocorticoid antagonists. Author Michel Azizi ... Show More
18m 21s
Mar 19
Update on Peanut Allergy
Peanut allergy affects about 2% of people in the US and most commonly develops in early childhood. Peanut introduction during infancy has led to decreased prevalence of peanut allergy. Author Elissa Abrams, MD, MPH, of the University of Manitoba joins JAMA Deputy Editor Kristin W ... Show More
18m 32s
Mar 9
Obesity-Related Cancer
Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity an ... Show More
21m 21s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Sep 2025
Urinary Tract Malignancies
Send a textNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob dive into the essential clinical and pathophysiologic features of urinary tract malignancies, beginning with renal cell carcinoma (RCC) and followed by urothelial carcinoma of the bladder.We start with ... Show More
29m 41s
Nov 2023
S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?
Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991606). The topics and ... Show More
29m 23s
Oct 2023
S2 Episode 5: When Is It Time to Talk About Kidney Transplantation?
Join experts Drs Matthew Sparks and Samira Farouk as they pull back the curtain to help patients and providers better understand the transplant journey. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991605). The to ... Show More
28m 50s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Mar 2025
Surgical Oncology, Part 2
In the second episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is once again joined by Drs. John Stewart and Prakash Pendalai to discuss the important features of head and neck malignancies, benign and malignant gynecologic conditions, and principles ... Show More
19 m
Nov 2024
Surgical Oncology, Part 1
In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a ... Show More
28m 14s
Jul 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More
17m 45s
Jul 2025
Clinical Challenges in Colorectal Surgery: Early Onset Colorectal Cancer
<div>The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we pr ... Show More
38m 35s
Jun 2022
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
<p>Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease.</p> <p>However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored ... Show More
11m 24s
Listen to millions of songs and podcasts on Anghami